Organon (OGN) Revenue (2020 - 2026)
Organon (OGN) posted quarterly Revenue of $1.6 billion for Q2 2026, down 2.26% year-over-year from $1.6 billion in Q2 2025, and up 6.71% on a QoQ basis from $1.5 billion in Q1 2026.
Organon (OGN) Revenue (2020 - 2026) Analysis & Trends
Organon has reported Revenue for 7 years, with the latest figure at $1.6 billion in Q2 2026.
- Revenue for Q2 2026 came in at $1.6 billion, down 2.26% year-over-year; the trailing twelve-month figure through Jun 2026 was $6.1 billion (down 2.45% YoY), and the FY2025 annual result was $6.2 billion, down 2.92% from the prior year.
- Revenue improved to $1.6 billion in Q2 2026, from $1.5 billion in the prior quarter.
- Over five years, Revenue peaked at $1.6 billion in Q1 2024 and troughed at $1.5 billion in Q1 2026.
- A 5-year average of $1.6 billion and a median of $1.6 billion in 2022 frame the typical range for Revenue.
- The widest annual swing landed in 2022, when Revenue declined 7.36%; it then advanced 7.61% in 2023.
- A 5-year view of Revenue shows it stood at $1.5 billion in 2022, then gained by 7.61% to $1.6 billion in 2023, then declined by 0.38% to $1.6 billion in 2024, then retreated by 5.34% to $1.5 billion in 2025, then rose by 3.38% to $1.6 billion in 2026.
- Per Business Quant data, the three most recent Revenue figures were $1.6 billion in Q2 2026, $1.5 billion in Q1 2026, and $1.5 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.33 Bn | 630.58 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 469.67 Bn | 463.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 374.13 Bn | 366.99 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 302.76 Bn | 295.07 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.15 Bn | 252.25 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 236.76 Bn | 222.77 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 182.54 Bn | 179.36 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 159.57 Bn | 147.87 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Gsk | 105.99 Bn | 101.83 Bn | 8.24 Bn | 11.28 Bn |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 1.56 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.56 Bn |
| Mar 31, 2026 | 1.46 Bn |
| Dec 31, 2025 | 1.51 Bn |
| Sep 30, 2025 | 1.60 Bn |
| Jun 30, 2025 | 1.59 Bn |
| Mar 31, 2025 | 1.51 Bn |
| Dec 31, 2024 | 1.59 Bn |
| Sep 30, 2024 | 1.58 Bn |
| Jun 30, 2024 | 1.61 Bn |
| Mar 31, 2024 | 1.62 Bn |
| Dec 31, 2023 | 1.60 Bn |
| Sep 30, 2023 | 1.52 Bn |
| Jun 30, 2023 | 1.61 Bn |
| Mar 31, 2023 | 1.54 Bn |
| Dec 31, 2022 | 1.49 Bn |
| Sep 30, 2022 | 1.54 Bn |
| Jun 30, 2022 | 1.59 Bn |
| Mar 31, 2022 | 1.57 Bn |
| Dec 31, 2021 | 1.60 Bn |
| Sep 30, 2021 | 1.60 Bn |